microdosing tirzepatide for maintenance 🚨Exciting News!🚨, We’re thrilled to

GLP-1 prescriptions, outpacing the combined 46% share of Novo Nordisk's Wegovy and its diabetes treatment Ozempic, according to Seigerman

10.1111/j.1749-6632.2012.06574.x [DOI] [PubMed] [Google Scholar] Brigelius-Floh R., Maiorino M

As a compounding pharmacist, I find this encouraging because it shows there's active discussion around therapies that many patients and providers have been asking about

New GLP-1 diabetes pill delivers major weight loss and blood sugar control A promising new diabetes pill could make powerful GLP-1 treatments much easier to use

Therefore, it supports ongoing weight control

Clarify the regulatory status of retatrutide and available alternatives : Your doctor can advise on whether approved alternatives may be more appropriate for your circumstances